urogenital neoplasms
Showing 1 - 25 of 39
Tumors, Kidney Tumors, Urologic Tumors Trial in Nanjing (Toripalimab, Axitinib, Lenvatinib)
Recruiting
- Neoplasms
- +12 more
- Toripalimab
- +3 more
-
Nanjing, Jiangsu, ChinaJinling Hospital, Affiliated Hospital of Medical School, Nanjing
Oct 28, 2023
Clinical Significance of Adherent Perinephric Fat in Patients
Recruiting
- Renal Cell Carcinoma
- +4 more
-
Otwock, PolandEuropean Health Centre, Second Department of Urology, Centre of
May 31, 2023
Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, mCRPC Trial in Glen Burnie (177Lu-rhPSMA-10.1 injection,
Recruiting
- Prostate Cancer
- +5 more
- 177Lu-rhPSMA-10.1 injection
- 18F-rhPSMA-7.3 injection
-
Glen Burnie, Maryland
- +3 more
Feb 2, 2023
Urothelial Cancer and Rare Genitourinary Tract Malignancies
Recruiting
- Urothelial Cancer
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Urothelial Cancer, Bladder Cancer, Genitourinary Cancer Trial run by the NCI (M7824, M9241, Stereotactic body radiation therapy
Recruiting
- Urothelial Cancer
- +4 more
- M7824
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Prostatic Tumors, Tumor Metastasis, Urogenital Tumors Trial in Worldwide (Abemaciclib, Abiraterone, Prednisone or Prednisolone)
Recruiting
- Prostatic Neoplasms
- +16 more
- Abemaciclib
- +3 more
-
Birmingham, Alabama
- +296 more
Jan 18, 2023
Prostatic Tumors, Castration-Resistant, Tumors by Histologic Type, Tumors, Prostate Trial in United States (P-PSMA-101 CAR-T
Active, not recruiting
- Prostatic Neoplasms, Castration-Resistant
- +16 more
- P-PSMA-101 CAR-T cells
- Rimiducid
-
Duarte, California
- +9 more
Nov 15, 2022
Uterine Cervical Tumor, Uterine Tumors, Genital Tumors, Female Trial in Seattle (Usual Care, Education, Direct Mail)
Active, not recruiting
- Uterine Cervical Neoplasm
- +13 more
- Usual Care
- +3 more
-
Seattle, WashingtonKaiser Permanente Washington Health Research Institute
Aug 16, 2022
Urogenital Tumors, Drug Therapy Trial in Campinas (Biopsy)
Completed
- Urogenital Neoplasms
- Drug Therapy
- Biopsy
-
Campinas, SP, BrazilHospital das ClĂnicas Unicamp
Jul 7, 2022
Carcinoma, Ovarian Tumor, Endocrine Gland Tumor Trial in Havana (Ocoxin-Viusid)
Completed
- Carcinoma
- +12 more
- Ocoxin-Viusid
-
Havana, CubaNational Institute of Oncology and Radiobiology (INOR)
Jul 5, 2022
Urogenital Tumors Trial (NanoDoce (sterile nanoparticulate docetaxel) Powder for Suspension)
Available
- Urogenital Neoplasms
- NanoDoce (sterile nanoparticulate docetaxel) Powder for Suspension
- (no location specified)
Apr 7, 2022
Prostate Cancer, Prostate Adenocarcinoma, Prostate Cancer Adenocarcinoma Trial in United States (NanoPac (sterile
Terminated
- Prostate Cancer
- +6 more
- NanoPac (sterile nanoparticulate paclitaxel) Powder for Suspension
-
Tampa, Florida
- +3 more
Mar 2, 2022
sidE eFfects of ImmuNotherapy:Possible Clue to Optimize cancEr
Recruiting
- Melanoma
- +4 more
-
Milano, ItalyFondazione IRCCS Istituto Nazionale dei Tumori
Jan 10, 2022
Prostate Tumor, Genital Tumors, Male, Urogenital Tumors Trial in Miami, Chicago (Cultural CBSM, Standard CBSM)
Recruiting
- Prostate Neoplasm
- +5 more
- Cultural CBSM
- Standard CBSM
-
Miami, Florida
- +1 more
Dec 2, 2021
Prostate Cancer, Prostatic Tumor, Prostatic Disease Trial in Vancouver ([68Ga]Ga-HTK03149 PET/CT)
Active, not recruiting
- Prostate Cancer
- +5 more
- [68Ga]Ga-HTK03149 PET/CT
-
Vancouver, British Columbia, CanadaBC Cancer
Dec 1, 2021
Bladder Cancer, Urothelial Carcinoma, Urinary Bladder Tumor Trial in United States (NanoDoce (direct injection), NanoDoce
Completed
- Bladder Cancer
- +8 more
- NanoDoce (direct injection)
- +3 more
-
Phoenix, Arizona
- +4 more
Nov 29, 2021
Urothelial Carcinoma, Anlotinib, Urogenital Tumors Trial in Tianjin (Anlotinib, Cisplatin, Carboplatin)
Not yet recruiting
- Urothelial Carcinoma
- +6 more
- Anlotinib
- +3 more
-
Tianjin, ChinaTianjin Medical Unversity Second Hospital
Aug 30, 2021
Urinary Bladder Tumors, Urologic Tumors, Urogenital Tumors Trial in Shanghai (tislelizumab and BCG)
Recruiting
- Urinary Bladder Neoplasms
- +5 more
- tislelizumab and BCG
-
Shanghai, Shanghai, ChinaRen Ji Hospital, School of Medicine, Shanghai Jiao Tong Universi
Jun 10, 2021
Urinary Bladder Tumor, Transitional Cell Carcinoma, Urogenital Tumors Trial in Hall In Tirol, Salzburg (Bipolar transurethral
Recruiting
- Urinary Bladder Neoplasm
- +4 more
- Bipolar transurethral resection of bladder tumor (TURBT)
- Bipolar transurethral plasma kinetic vaporization of bladder tumor (PKVBT)
-
Hall In Tirol, Austria
- +1 more
Mar 19, 2021
Metastatic Renal Cell Carcinoma, Kidney Tumor, Urologic Tumors Trial in Herlev (Medication (A specification is listed under each
Recruiting
- Metastatic Renal Cell Carcinoma
- +3 more
- Medication (A specification is listed under each arm)
- Patient reported outcomes measurement
-
Herlev, DenmarkDepartment of Oncology, Herlev and Gentofte Hospital
Nov 19, 2020
Ovarian Tumors, Fallopian Tube Tumors, Endocrine Gland Tumors Trial in Nanjing (Niraparib, Bevacizumab)
Unknown status
- Ovarian Neoplasms
- +23 more
-
Nanjing, Jiangsu, ChinaJiangSu Cancer Hospital
Nov 8, 2020
Prostate Cancer, Prostatic Tumor, Urogenital Tumors Trial in Modena ([68Ga]Ga-PSMA-11 PET/CT)
Recruiting
- Prostate Cancer
- +5 more
- [68Ga]Ga-PSMA-11 PET/CT
-
Modena, ItalyAzienda Ospedaliero-Universitaria di Modena
Sep 16, 2020